Recalling a 2012 California Alzheimer's Effort: A Case of 'Clutching at Straws'Says LA Times Columnist
California’s stem cell agency, which is working mightily to develop a commercially viable stem cell treatment, popped up this week in the heated national debate about federal approval of a treatment for Alzheimer’s.
The therapy in question is Aduhelm. Here is how Michael Hiltzik, author of “Big Science” and business columnist for the Los Angeles Times, y…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.